[1] 韦平. 重要动物病毒分子生物学. 北京: 科学出版社, 2008: 501-516.
WEI P. Molecular Biology of Important Animal Virus. Beijing: Science Press, 2008: 501-516. (in Chinese)
[2] 刘光清. 动物病毒反向遗传学(二版). 北京: 科学出版社, 2014: 493-536.
LIU G Q. Reverse Genetics of Animal Virus(2nd edition). Beijing: Science Press, 2014: 493-536. (in Chinese)
[3] DARTEIL R, BUBLOT M, LAPLACE E, BOUQUET J F, AUDONNET J C, RIVIÈRE M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology1995, 211(2): 481-490. ,
[4] LIU S, SUN W, CHU J, HUANG X, WU Z, YAN M, ZHANG Q, ZHAO P, IGIETSEME JU, BLACK CM, HE C, LI Y. Construction of recombinant HVT expressing PmpD, and immunological evaluation against Chlamydia psittaci and Marek's Disease Virus. PLoS One, 2015, 10(4): e0124992.
[5] KAPCZYNSKI D R, ESAKI M, DORSEY K M, JIANG H, JACKWOOD M, MORAES M, GARDIN Y. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2. 2 avian influenza virus. Vaccine, 2015, 33(9): 1197-1205.
[6] KLINGBEIL K, LANGE E, TEIFKE J P, METTENLEITER T C, FUCHS W. Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus. Journal of General Virology, 2014, 95(Pt 4): 948-959.
[7] 邓晓辉, 陈柳, 叶伟成, 李军星, 崔尚金, 余斌, 云涛, 崔言顺, 孙元, 仇华吉, 张帅, 张存. 共表达猪细小病毒VP2蛋白和猪圆环病毒2型Cap蛋白的重组伪狂犬病毒的构建及其鉴定. 中国预防兽医学报, 2012, 34(4): 251-256.
DENG X H, CHEN L, YE W C, LI J X, CUI S J, YU B, YUN T, CUI Y S, SUN Y, QIU H J, ZHANG S, ZHANG C. Construction and characterization of a recombinant pseudorabies virus expressing VP2 of porcine parvovirus and Cap of porcine circovirus type 2. Chinese Journal of Preventive Veterinary Medicine, 2012, 34(4): 251-256. (in Chinese)
[8] GIMENO I M, CORTES A L, FAIZ N M, HERNANDEZ-ORTIZ B A, GUY J S, HUNT H D, SILVA R F. Evaluation of the protection efficacy of a serotype 1 Marek's disease virus-vectored bivalent vaccine against infectious laryngotracheitis and Marek's disease. Avian Diseases, 2015, 59(2): 255-262.
[9] ZHANG Z, MA C, ZHAO P, DUAN L, CHEN W, ZHANG F, CUI Z. Construction of recombinant Marek's disease virus (rMDV) co- expressing AIV-H9N2-NA and NDV-F genes under control of MDV's own bi-directional promoter. PLoS One, 2014, 9(3): e9067.
[10] SAID A, LANGE E, BEER M, DAMIANI A, OSTERRIEDER N. Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09. Virus Research, 173(2): 371-376.
[11] SAID A, DAMIANI A, MA G, KALTHOFF D, BEER M, OSTERRIEDER N. An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1. Veterinary Microbiology, 2011, 154(1-2): 113-123.
[12] VAN DE WALLE G R, MAY M A, PETERS S T, METZGER S M, ROSAS C T, OSTERRIEDER N. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Vaccine, 2010, 28(4): 1048-1055.
[13] REN X G, XUE F, ZHU Y M, TONG G Z, WANG Y H, FENG J K, SHI H F, GAO Y R. Construction of a recombinant BHV-1 expressing the VP1 gene of foot and mouth disease virus and its immunogenicity in a rabbit model. Biotechnology Letters2009, 31(8): 1159-1165. ,
[14] SCHRIJVER R S, LANGEDIJK J P, KEIL G M, MIDDEL W G, MARIS-VELDHUIS M, VAN OIRSCHOT J T, RIJSEWIJK F A. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine1997, 15(17-18): 1908-1916. ,
[15] DONOFRIO G, CAVIRANI S, SIMONE T, VAN SANTEN V L. Potential of bovine herpesvirus 4 as a gene delivery vector. Journal of Virological Methods, 2002, 101(1-2): 49-61.
[16] CAPOCEFALO A, MANGIA C, FRANCESCHI V, JACCA S, VAN SANTEN V L, DONOFRIO G. Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector. Vaccine, 2013, 31(37): 3906-3914.
[17] DONOFRIO G, FRANCESCHI V, LOVERO A, CAPOCEFALO A, CAMERO M, LOSURDO M, CAVIRANI S, MARINARO M, GRANDOLFO E, BUONAVOGLIA C, TEMPESTA M. Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD. PLoS One, 2013, 8(1): e52758.
[18] LI Y, HUANG B, MA X, WU J, LI F, AI W, SONG M, YANG H. Molecularcharacterization of the genome of duck enteritis virus. Virology, 2009, 391: 151-161.
[19] WANG J, OSTERRIEDER N. Generation of an infectious clone of duck enteritis virus (DEV) and of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus. Virus Research, 2011, 159(1): 23-31.
[20] CHEN L, YU B, HUA J, YE W, NI Z, YUN T, DENG X, ZHANG C. Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain. Virology Journal, 2013, 10: 328.
[21] WANG J, GE A, XU M, WANG Z, QIAO Y, GU Y, LIU C, LIU Y, HOU J. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens. Virology Journal, 2015, 12: 126.
[22] ZOU Z, HU Y, LIU Z, ZHONG W, CAO H, CHEN H, JIN M. Efficient strategy for constructing duckenteritisvirus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duckenteritisvirus infection. Veterinary Microbiology, 2015, 46: 42.
[23] LIU J, CHEN P, JIANG Y, WU L, ZENG X, TIAN G, GE J, KAWAOKA Y, BU Z, CHEN H. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. Journal of Virology, 2011, 85(21): 10989-10998.
[24] LIU J, CHEN P, JIANG Y, DENG G, SHI J, WU L, LIN Y, BU Z, CHEN H. Recombinant duck enteritis virus works as a single-dose vaccine in broilers providing rapid protection against H5N1 influenza infection. Antiviral Research, 2013, 97(3): 329-333.
[25] LIU X, WEI S, LIU Y, FU P, GAO M, MU X, LIU H, XING M, MA B, WANG J. Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus. Vaccine, 2013, 31(50): 5953-5959.
[26] CHEN P, LIU J, JIANG Y, ZHAO Y, LI Q, WU L, HE X, CHEN H. The vaccine efficacy of recombinant duck enteritis virus expressing secreted E with or without PrM proteins of duck tembusu virus. Vaccine, 2014, 32(41): 5271-5277.
[27] ZOU Z, LIU Z, JIN M. Efficient strategy to generate a vectored duck enteritis virus delivering envelope of duck Tembusu virus. Viruses, 2014, 6(6): 2428-2443.
[28] 陈柳, 余斌, 倪征, 华炯钢, 叶伟成, 云涛, 张存. 表达鸭坦布苏病毒E蛋白的重组鸭瘟病毒的构建及其生物学特性研究. 浙江农业学报, 2015, 27(11): 1889-1895.
CHEN L, YU B, NI Z, HUA J, YE W, YUN T, Zhang C. Construction and characterization of a recombinant duck enteritis virus expressing E protein of duck Tembusu virus. Acta Agriculturae Zhejiangensis, 2015, 27(11): 1889-1895. (in Chinese)
[29] JU H, WEI N, WANG Q, WANG C, JING Z, GUO L, LIU D, GAO M, MA B, WANG J. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose. Biochemicaland Biophysical Research Communications, 2011, 409(1): 131-136.
[30] TISCHER B K, VON EINEM J, KAUFER B, OSTERRIEDER N. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques, 2006, 40(2): 191-197.
[31] TISCHER B K, SMITH G A, OSTERRIEDER N. En passant mutagenesis: a two step markerless red recombination system. Methods Molecular Biology, 2010, 634: 421-430.
[32] 李茂祥, 李俊宝, 郑玉美. 小鹅瘟病毒纯化及其理化特性的研究. 病毒学报, 1990, 6(2): 155-159.
LI M X, LI J B, ZHENG Y M. Purification and physico-chemical characteristics of a goslin plaque virus. Chinese Journal of Virology, 1990, 6(2): 155-159. (in Chinese)
[33] 殷震. 动物病毒学(二版). 北京: 科学出版社, 1997: 1165-1168.
YIN Z, LIU J. Aminal Virology (2nd edition). Beijing: Science Press, 1997: 1165-1168. (in Chinese)
[34] LEE J W, LIN Y M, YEN T Y, YANG W J, CHU C Y. CpG oligodeoxynucleotides containing GACGTT motifs enhance the immuneresponses elicited by a goose parvovirus vaccine inducks. Vaccine, 2010, 28: 7956-7962.
[35] CHEN Z, LI C, ZHU Y, WANG B, MENG C, LIU G. Immunogenicity of virus-like particles containing modified goose parvovirus VP2protein. Virus Research, 2012, 169: 306- 309. |